<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1314">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 08, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04706260</url>
  </required_header>
  <id_info>
    <org_study_id>7839</org_study_id>
    <nct_id>NCT04706260</nct_id>
  </id_info>
  <brief_title>Clinical Evolution and Becoming of Adult Patients Infected With Covid-19 Hospitalized at Strasbourg University Hospitals</brief_title>
  <official_title>Clinical Evolution and Becoming of Adult Patients Infected With Covid-19 Hospitalized at the University Hospitals of Strasbourg : A Retrospective Observational Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A SARS-CoV-2 infection emerged in China in December 2019, the severity of which is linked to&#xD;
      acute respiratory distress syndrome1. The rate of emergency visits in Bas-Rhin for suspected&#xD;
      Covid-19 increased, compared to the French average, at the end of the 10th week of 2020.&#xD;
&#xD;
      Compared to the onset of symptoms, Chinese studies estimate the onset of dyspnea on the 7th&#xD;
      day3 and admission to the emergency room between the 5th and the 9th day4. But this duration&#xD;
      varies according to the epidemic period5, the geographical location6 and a later emergency&#xD;
      admission is associated with an increase in mortality in the Chinese population7.&#xD;
&#xD;
      The need for oxygen, which is not noted in Chinese studies8, is a reflection of the onset of&#xD;
      respiratory worsening and a major factor in hospitalization. There is no study on the&#xD;
      changing profile of the French population to date its onset.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 14, 2020</start_date>
  <completion_date type="Anticipated">April 14, 2021</completion_date>
  <primary_completion_date type="Anticipated">April 14, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Retrospective evaluation of the clinical evolution and becoming of adult patients infected with Covid-19 hospitalized at the University Hospitals of Strasbourg from the Emergency Structure</measure>
    <time_frame>Files analysed retrospectily from March 06, 2020 to April 05, 2020 will be examined]</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Covid-19</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patient with covid-19 hospitalized at HUS between 06/03/2020 and 05/04/2020.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male or female aged 18 or over&#xD;
&#xD;
          -  Admitted to the NHC emergency room and hospitalized at the Strasbourg University&#xD;
             Hospitals (HUS) between 06/03/2020 and 05/04/2020.&#xD;
&#xD;
          -  With SARS-CoV-2 RT-PCR on a positive nasopharyngeal sample taken at the SU.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Refusal to participate in the study&#xD;
&#xD;
          -  Return home from the SU&#xD;
&#xD;
          -  Transfer to another establishment&#xD;
&#xD;
          -  Patient under the protection of justice&#xD;
&#xD;
          -  Patient under guardianship, curatorship&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mathieu OBERLIN, MD</last_name>
    <role>Study Director</role>
    <affiliation>Adult Emergency Department - Strasbourg University Hospitals</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mathieu OBERLIN, MD</last_name>
    <phone>33 3 88 12 79 85</phone>
    <email>mathieu.oberlin@chru-strasbourg.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Saïd CHAYER, PhD, HDR</last_name>
    <phone>33 3 88 11 66 90</phone>
    <email>said.chayer@chru-strasbourg.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Adult Emergency Department - Strasbourg University Hospitals</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mathieu OBERLIN, MD</last_name>
      <phone>33 3 88 12 79 85</phone>
      <email>mathieu.oberlin@chru-strasbourg.fr</email>
    </contact>
    <contact_backup>
      <last_name>Saïd CHAYER, PhD, HDR</last_name>
      <phone>33 3 88 11 66 90</phone>
      <email>said.chayer@chru-strasbourg.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Mathieu OBERLIN, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tamara SANTIAGO, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 8, 2021</study_first_submitted>
  <study_first_submitted_qc>January 8, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 12, 2021</study_first_posted>
  <last_update_submitted>January 8, 2021</last_update_submitted>
  <last_update_submitted_qc>January 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>COVID-19</keyword>
  <keyword>COVID-19 Pandemic</keyword>
  <keyword>Sars-cov-2</keyword>
  <keyword>Emergency Department</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

